Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Martinez

Showing results (471-480 of 754) with videos related to

Pageof 76
Sort By:
JACC. Cardiovascular Imaging|March 7, 2023
Machine Learning to Optimize the Echocardiographic Follow-Up of Aortic StenosisAntonio Sánchez-Puente, P Ignacio Dorado-Díaz, Jesús Sampedro-Gómez, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 29, 2014
Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendationsArthur S Walters, Birgit Frauscher, Richard Allen, et al.
IEEE Transactions on Bio-Medical Engineering|April 22, 2016
On the Influence of Heart Rate and Coupling Interval Prematurity on Heart Rate TurbulenceOscar Barquero-Perez, Carlos Figuera, Rebeca Goya-Esteban, et al.
Science Translational Medicine|March 23, 2022
The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's diseaseMiguel Moutinho, Shweta S Puntambekar, Andy P Tsai, et al.
Journal of the Neurological Sciences|November 5, 2013
Comparison of the clinical profile of Parkinson's disease between Spanish and Cameroonian cohortsEsther Cubo, Jacques Doumbe, Pablo Martinez-Martin, et al.
Cell Reports|July 13, 2024
Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer's progressionJuan F Codocedo, Claudia Mera-Reina, Peter Bor-Chian Lin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2024
Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert ConsensusInes Debove, Steffen Paschen, Deborah Amstutz, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 19, 2026
Accelerometer-derived daily steps, cognition, and cognitive impairment in U.S. community-dwelling older adults: The Atherosclerosis Risk in Communities StudyPablo Martinez-Amezcua, Wuyang Zhang, Erin E Dooley, et al.
Movement Disorders Clinical Practice|February 5, 2019
A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's DiseaseKallol Ray Chaudhuri, Antoniya Todorova, Melissa J Nirenberg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 16, 2008
Anxiety rating scales in Parkinson's disease: critique and recommendationsAlbert F G Leentjens, Kathy Dujardin, Laura Marsh, et al.
Pageof 76

Showing results (471-480 of 754) with videos related to

Sort By:
Pageof 76
JACC. Cardiovascular Imaging|March 7, 2023
Machine Learning to Optimize the Echocardiographic Follow-Up of Aortic StenosisAntonio Sánchez-Puente, P Ignacio Dorado-Díaz, Jesús Sampedro-Gómez, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 29, 2014
Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendationsArthur S Walters, Birgit Frauscher, Richard Allen, et al.
IEEE Transactions on Bio-Medical Engineering|April 22, 2016
On the Influence of Heart Rate and Coupling Interval Prematurity on Heart Rate TurbulenceOscar Barquero-Perez, Carlos Figuera, Rebeca Goya-Esteban, et al.
Science Translational Medicine|March 23, 2022
The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's diseaseMiguel Moutinho, Shweta S Puntambekar, Andy P Tsai, et al.
Journal of the Neurological Sciences|November 5, 2013
Comparison of the clinical profile of Parkinson's disease between Spanish and Cameroonian cohortsEsther Cubo, Jacques Doumbe, Pablo Martinez-Martin, et al.
Cell Reports|July 13, 2024
Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer's progressionJuan F Codocedo, Claudia Mera-Reina, Peter Bor-Chian Lin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2024
Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert ConsensusInes Debove, Steffen Paschen, Deborah Amstutz, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 19, 2026
Accelerometer-derived daily steps, cognition, and cognitive impairment in U.S. community-dwelling older adults: The Atherosclerosis Risk in Communities StudyPablo Martinez-Amezcua, Wuyang Zhang, Erin E Dooley, et al.
Movement Disorders Clinical Practice|February 5, 2019
A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's DiseaseKallol Ray Chaudhuri, Antoniya Todorova, Melissa J Nirenberg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 16, 2008
Anxiety rating scales in Parkinson's disease: critique and recommendationsAlbert F G Leentjens, Kathy Dujardin, Laura Marsh, et al.
Pageof 76